Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Giovanna Ricci, Francesco Paolo Busardò, Filippo Gibelli, Ascanio Sirignano & Pietro Brunetti. (2021) Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1445-1454.
Read now
Read now
Benedicte Jørgenrud, Håvard Furuhaugen & Hallvard Gjerde. (2021) Prevalence and Correlates of Illicit Drug Use among Norwegian Nightlife Patrons. Substance Use & Misuse 56:11, pages 1697-1706.
Read now
Read now
Yanhui Liao, Yi-lang Tang & Wei Hao. (2017) Ketamine and international regulations. The American Journal of Drug and Alcohol Abuse 43:5, pages 495-504.
Read now
Read now
Amy Pennay. (2015) “What goes up must go down”: An exploration of the relationship between drug-related pleasure and harm experienced by a sample of regular “party drug” users. Drugs: Education, Prevention and Policy 22:3, pages 185-192.
Read now
Read now
Gina Martin, Kate Vallance, Scott Macdonald, Tim Stockwell, Andrew Ivsins, Clifton Chow, Warren Michelow & Cameron Duff. (2014) Nonfatal overdose from alcohol and/or drugs among a sample of recreational drug users. Journal of Substance Use 19:3, pages 239-244.
Read now
Read now
Leo J Schep, Kai Knudsen, Robin J Slaughter, J Allister Vale & Bruno Mégarbane. (2012) The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clinical Toxicology 50:6, pages 458-470.
Read now
Read now
Jih-Heng Li, Balasingam Vicknasingam, Yuet-Wah Cheung, Wang Zhou, Adhi Wibowo Nurhidayat, Don C Des Jarlais & Richard Schottenfeld. (2011) To use or not to use: an update on licit and illicit ketamine use. Substance Abuse and Rehabilitation 2, pages 11-20.
Read now
Read now
Joseph Ciorciari & Alicia Marotte. (2011) Implications of MDMA use for prospective memory function and substance use patterns in an Australian sample: A web‐based pilot study. Australian Journal of Psychology 63:3, pages 142-149.
Read now
Read now
Bryan E. Denham. (2009) Association Between Narcotic Use and Anabolic-Androgenic Steroid Use Among American Adolescents. Substance Use & Misuse 44:14, pages 2043-2061.
Read now
Read now
BrianC. Kelly. (2009) Mediating MDMA-Related Harm: Preloading and Post-loading Among Ecstasy-Using Youth. Journal of Psychoactive Drugs 41:1, pages 19-26.
Read now
Read now
Karen Joe-Laidler & Geoffery Hunt. (2008) Sit Down to Float: The Cultural Meaning of Ketamine Use in Hong Kong. Addiction Research & Theory 16:3, pages 259-271.
Read now
Read now
Lydia N. Drumright, Thomas L. Patterson & Steffanie A. Strathdee. (2006) Club Drugs as Causal Risk Factors for HIV Acquisition Among Men Who Have Sex with Men: A Review. Substance Use & Misuse 41:10-12, pages 1551-1601.
Read now
Read now
Articles from other publishers (71)
L. Lucuta, A. Maas-Gramlich, M. Kraemer, H. Andresen-Streichert & M. Juebner. (2024) Ketamine in DUID cases in the greater Cologne area. Forensic Science International 354, pages 111905.
Crossref
Crossref
Kedi Jiao, Haochu Li, Dapeng Zhang, Zhenxia Jiang, Yuxi Lin, Xueyuan Liu, Hengmin Xu, Xuemei Yan, Haoqing Tang & Wei Ma. (2022) Drug users’ awareness of and willingness to use HIV non-occupational post-exposure prophylaxis (nPEP) services in China: a mixed methods study. BMC Infectious Diseases 22:1.
Crossref
Crossref
Mark D. Salter & Naren Gunja. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
381
414
.
Wei J. Chen, Chi-Ya Chen, Shang-Chi Wu, Kevin Chien-Chang Wu, Susyan Jou, Yu-Chi Tung & Tzu-Pin Lu. (2021) The impact of Taiwan’s implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017. Harm Reduction Journal 18:1.
Crossref
Crossref
John Martin Corkery, Wan-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S Copeland & Fabrizio Schifano. (2021) Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019. Journal of Psychopharmacology 35:11, pages 1324-1348.
Crossref
Crossref
Mei-Ting Li, Jun Zhang, Dong-Cheng Zhang, Qing-Qing Che, Ze-Lan Liu, Pei-Wen Yang, Xin-Wei Luo & Tai-Sheng Cai. (2021) Development and Psychometric Properties of the Synthetic Drug Dependence Scale in a Chinese Sample. Frontiers in Psychology 12.
Crossref
Crossref
Raymen R. Assaf & Kelly D. Young. (2021) Trends in Pediatric Recreational Drug Use and Ingestions. Advances in Pediatrics 68, pages 261-281.
Crossref
Crossref
Wen‐Hsuan Pan, Kevin Chien‐Chang Wu, Chi‐Ya Chen, Yu‐Roo Chu, Shang‐Chi Wu, Susyan Jou, Tzu‐Pin Lu, Yu‐Chi Tung, Jui Hsu & Wei J. Chen. (2020) First‐time offenders for recreational ketamine use under a new penalty system in Taiwan: incidence, recidivism and mortality in national cohorts from 2009 to 2017. Addiction 116:7, pages 1770-1781.
Crossref
Crossref
Tat Leong Wu, Te-Tien Ting, Chuan-Yu Chen, Lien-Wen Su & Wei J. Chen. (2020) Early sexual initiation and risky sexual practices among alcohol- and tobacco-using young adults in Taiwan: mediation analysis of preceding-sex use of illicit drugs. BMC Public Health 20:1.
Crossref
Crossref
Jefferson P. Galvanho, Alex C. Manhães, Ana Cristina C. Carvalho-Nogueira, Joyce de M. Silva, Claudio C. Filgueiras & Yael Abreu-Villaça. (2020) Profiling of behavioral effects evoked by ketamine and the role of 5HT2 and D2 receptors in ketamine-induced locomotor sensitization in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 97, pages 109775.
Crossref
Crossref
Maria A. Aguilar, Maria P. García-Pardo & Andrew C. Parrott. (2020) Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’). Brain Research 1727, pages 146556.
Crossref
Crossref
Luther Elliott, Christopher Keith Haddock, Stephanie Campos & Ellen Benoit. (2019) Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities. PLOS ONE 14:12, pages e0225273.
Crossref
Crossref
Biao Zhou, Gao Feng Cai, Hua Kun Lv, Shuang Fei Xu, Zheng Ting Wang, Zheng Gang Jiang, Chong Gao Hu & Yong Di Chen. (2019) Factors Correlating to the Development of Hepatitis C Virus Infection among Drug Users—Findings from a Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 16:13, pages 2345.
Crossref
Crossref
André Schwertner, Maxciel Zortea, Felipe V. Torres & Wolnei Caumo. (2018) Effects of Subanesthetic Ketamine Administration on Visual and Auditory Event-Related Potentials (ERP) in Humans: A Systematic Review. Frontiers in Behavioral Neuroscience 12.
Crossref
Crossref
José Coelho Neto, Renata F.P. Faraco, Cíntia F. Alves, Stela M.M. Castro & Yuri Machado. (2018) Genuine sildenafil tablets sold in Brazil disguised as MDMA. Forensic Science International 283, pages e8-e12.
Crossref
Crossref
Erwan Le Garff, Vadim Mesli, Raphael Cornez, Christophe Demarly, Gilles Tournel & Valery Hédouin. (2018) Fatal Overdose of Gamma-hydroxybutyrate Acid After Ingestion of 1,4-Butanediol. Journal of Forensic Sciences 63:1, pages 326-329.
Crossref
Crossref
Desiree Madah-Amiri, Lars Myrmel & Guttorm Brattebø. (2017) Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 25:1.
Crossref
Crossref
Dian-Shi WangAntonello PennaBeverley A. Orser. (2017) Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons. Anesthesiology 126:4, pages 666-677.
Crossref
Crossref
Ghorbangol Ashabi, Mitra-Sadat Sadat-Shirazi, Solmaz Khalifeh, Laleh Elhampour & Mohammad-Reza Zarrindast. (2017) NMDA receptor adjusted co-administration of ecstasy and cannabinoid receptor-1 agonist in the amygdala via stimulation of BDNF/Trk-B/CREB pathway in adult male rats. Brain Research Bulletin 130, pages 221-230.
Crossref
Crossref
Runtao Ding, Yanning Li, Ao Du, Hao Yu, Bolin He, Ruipeng Shen, Jichuan Zhou, Lu Li, Wen Cui, Guohua Zhang, Yan Lu & Xu Wu. (2016) Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity. Scientific Reports 6:1.
Crossref
Crossref
Roya Noori, Ali Farhoudian, Hooman Naranjiha, Mohammad Hassan Farhadi, Kate Dolan & Hamid-Reza Khoddami-Vishteh. (2016) Comparison of Characteristics of Methamphetamine Versus Opiate Users in Tehran, Iran. International Journal of High Risk Behaviors and Addiction 5:4.
Crossref
Crossref
Christopher M. Plummer, Thomas W. Breadon, James R. Pearson & Oliver A.H. Jones. (2016) The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities. Science & Justice 56:3, pages 223-230.
Crossref
Crossref
Sijie Tan, Ju Zou, Meixiang Li & David T. Yew. (2016) Chronic effects of ketamine on gene expression changes in neurotransmitter receptors and regulators-A PCR-array study. Molecular & Cellular Toxicology 11:4, pages 395-400.
Crossref
Crossref
R. Giorgetti, D. Marcotulli, A. Tagliabracci & F. Schifano. (2015) Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability. Forensic Science International 252, pages 127-142.
Crossref
Crossref
Olga S. Cruz. (2014) Nonproblematic Illegal Drug Use. Journal of Drug Issues 45:2, pages 133-150.
Crossref
Crossref
Hanna Uosukainen, Ulrich Tacke & Adam R. Winstock. (2015) Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. International Journal of Drug Policy 26:1, pages 78-83.
Crossref
Crossref
Timothy Gould, Lixin Chen, Zsuzsa Emri, Tiina Pirttimaki, Adam C. Errington, Vincenzo Crunelli & H. Rheinallt Parri. (2014)
GABA
B
receptor-mediated activation of astrocytes by gamma-hydroxybutyric acid
. Philosophical Transactions of the Royal Society B: Biological Sciences 369:1654, pages 20130607.
Crossref
Crossref
Hong Chai Tang, Wai Ping Lam, Xin Zhang, Ping-Chung Leung, David T. Yew & Willmann Liang. (2014) Chronic ketamine treatment-induced changes in contractility characteristics of the mouse detrusor. International Urology and Nephrology 46:8, pages 1563-1571.
Crossref
Crossref
Anke Hübler, Mike Hänsel & Matthias Hübler. 2014. Komplikationen in der Anästhesie. Komplikationen in der Anästhesie
333
340
.
Anke Hübler, Mike Hänsel, Karen B. Domino & Matthias Hübler. 2014. Complications and Mishaps in Anesthesia. Complications and Mishaps in Anesthesia
295
301
.
Yingying Ding, Na He, Weiming Zhu & Roger Detels. (2012) Sexual Risk Behaviors among Club Drug Users in Shanghai, China: Prevalence and Correlates. AIDS and Behavior 17:7, pages 2439-2449.
Crossref
Crossref
Qi Li, Wai Man Chan, John A. Rudd, Chun Mei Wang, Phoebe Y.H. Lam, Maria Sen Mun Wai, David M. Wood, Paul I. Dargan & David T. Yew. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
285
316
.
Roumen Sedefov, Ana Gallegos, Jane Mounteney & Padraigin Kenny. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
29
54
.
Maria Angé licade Castro Comis & Ana Regina Noto. (2012) Reasons for not using ecstasy: a qualitative study of non-users, ex-light users and ex-moderate users. BMC Public Health 12:1.
Crossref
Crossref
Naren Gunja. (2012) Teenage toxins: Recreational poisoning in the adolescent. Journal of Paediatrics and Child Health 48:7, pages 560-566.
Crossref
Crossref
Matthias Hübler & Thea Koch. 2012. Komplikationen in der Anästhesie. Komplikationen in der Anästhesie
317
324
.
Sijie Tan, John A. Rudd & David T. Yew. (2011) Gene Expression Changes in GABAA Receptors and Cognition Following Chronic Ketamine Administration in Mice. PLoS ONE 6:6, pages e21328.
Crossref
Crossref
Dan Wood, Angela Cottrell, Simon C. Baker, Jennifer Southgate, Maya Harris, Simon Fulford, Christopher Woodhouse & David Gillatt. (2011) Recreational ketamine: from pleasure to pain. BJU International 107:12, pages 1881-1884.
Crossref
Crossref
Z. Mohtasham-Amiri, A. Jafari-Shakib & A. Khalili-Moosavi. (2011) Prevalence and factors associated with Ecstasy use among college undergraduates in north of Iran—2005. Asian Journal of Psychiatry 4:1, pages 31-34.
Crossref
Crossref
Ujjwal P. Ramtekkar, Catherine W. Striley & Linda B. Cottler. (2011) Contextual profiles of young adult ecstasy users: A multisite study. Addictive Behaviors 36:3, pages 190-196.
Crossref
Crossref
David W. Pantalone, David S. Bimbi, Catherine A. Holder, Sarit A. Golub & Jeffrey T. Parsons. (2010) Consistency and Change in Club Drug Use by Sexual Minority Men in New York City, 2002 to 2007. American Journal of Public Health 100:10, pages 1892-1895.
Crossref
Crossref
Zsófia Németh, Bernadette Kun & Zsolt Demetrovics. (2010) Review: The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review. Journal of Psychopharmacology 24:9, pages 1281-1287.
Crossref
Crossref
Alison Oliveto, William Brooks Gentry, Rhonda Pruzinsky, Kishorchandra Gonsai, Thomas R. Kosten, Bridget Martell & James Poling. (2010) Behavioral effects of γ-hydroxybutyrate in humans. Behavioural Pharmacology 21:4, pages 332-342.
Crossref
Crossref
ROBSON NOORZURANI, BALASINGAM VICKNASINGAM & SURESH NARAYANAN. (2010) Illicit ketamine induced frequency of micturition in a young Malay woman. Drug and Alcohol Review 29:3, pages 334-336.
Crossref
Crossref
Adam Fazio, Karen Joe-Laidler, Molly Moloney & Geoffrey Hunt. (2010) Gender, Sexuality, and Ethnicity as Factors of Club-Drug Use among Asian Americans. Journal of Drug Issues 40:2, pages 405-432.
Crossref
Crossref
Jill Watson, Sara Guzzetti, Carlotta Franchi, Angelo Di Clemente, Silvia Burbassi, Zsuzsa Emri, Nathalie Leresche, H. Rheinallt Parri, Vincenzo Crunelli & Luigi Cervo. (2009) Gamma-hydroxybutyrate does not maintain self-administration but induces conditioned place preference when injected in the ventral tegmental area. The International Journal of Neuropsychopharmacology 13:02, pages 143.
Crossref
Crossref
Vibeke S. Catts & Stanley V. Catts. 2011. Secondary Schizophrenia. Secondary Schizophrenia
141
168
.
RAFAEL DE LA TORRE. (2009)
Commentary on Morgan
et al.
(2010): Ketamine abuse: first medical evidence of harms we should confront
. Addiction 105:1, pages 134-135.
Crossref
Crossref
Matthias Hübler & Thea Koch. 2010. Komplikationen in der Anästhesie. Komplikationen in der Anästhesie
315
322
.
Carmen Pedraza, Francisca Belén García & José Francisco Navarro. (2009) Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats. The International Journal of Neuropsychopharmacology 12:09, pages 1165.
Crossref
Crossref
Laurent Karila, Johanne Novarin, Bruno Megarbane, Olivier Cottencin, Sylvain Dally, William Lowenstein & Michel Reynaud. (2009) Acide gamma-hydroxy-butyrique (GHB) : plus qu’un agent de soumission chimique, une véritable source d’addiction. La Presse Médicale 38:10, pages 1526-1538.
Crossref
Crossref
Matthew Dunn, Libby Topp & Louisa Degenhardt. (2009) GHB in Sydney, Australia, 2000–2006: A case study of the EDRS as a strategic early warning system. International Journal of Drug Policy 20:5, pages 413-417.
Crossref
Crossref
Lawrence P. Carter, Daniel Pardi, Jane Gorsline & Roland R. Griffiths. (2009) Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem®): Differences in characteristics and misuse. Drug and Alcohol Dependence 104:1-2, pages 1-10.
Crossref
Crossref
Filippia Aroni, Nicoletta Iacovidou, Ismene Dontas, Chryssa Pourzitaki & Theodoros Xanthos. (2009) Pharmacological Aspects and Potential New Clinical Applications of Ketamine: Reevaluation of an Old Drug. The Journal of Clinical Pharmacology 49:8, pages 957-964.
Crossref
Crossref
Sophie C. Turfus, Mark C. Parkin, David A. Cowan, John M. Halket, Norman W. Smith, Robin A. Braithwaite, Simon P. Elliot, Glyn B. Steventon & Andrew T. Kicman. (2009) Use of Human Microsomes and Deuterated Substrates: An Alternative Approach for the Identification of Novel Metabolites of Ketamine by Mass Spectrometry. Drug Metabolism and Disposition 37:8, pages 1769-1778.
Crossref
Crossref
Laloup Marleen, Samyn Nele & De Boeck Gert. 2009. Wiley Encyclopedia of Forensic Science. Wiley Encyclopedia of Forensic Science.
Louisa Degenhardt & Matthew Dunn. (2008) The epidemiology of GHB and ketamine use in an Australian household survey. International Journal of Drug Policy 19:4, pages 311-316.
Crossref
Crossref
Natalie J. Loxton, Venice L.-N. Wan, Ada M.-C. Ho, Ben K.-L. Cheung, Nicole Tam, Freedom Y.K. Leung & Alfreda Stadlin. (2008) Impulsivity in Hong Kong-Chinese club-drug users. Drug and Alcohol Dependence 95:1-2, pages 81-89.
Crossref
Crossref
Paul Lee & Lesley V. Campbell. (2008) Diabetic Ketoacidosis: the Usual Villain or a Scapegoat?. Diabetes Care 31:3, pages e13-e13.
Crossref
Crossref
Fabrizio Schifano, John Corkery, Adenekan Oyefeso, Thomy Tonia & Abdol Hamid Ghodse. (2008) Trapped in the "K-hole". Journal of Clinical Psychopharmacology 28:1, pages 114-116.
Crossref
Crossref
Harry R. Sumnall, Kerry Woolfall, Sara Edwards, Jon C. Cole & Caryl M. Beynon. (2008) Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug and Alcohol Dependence 92:1-3, pages 286-290.
Crossref
Crossref
Rosa Alati, Stuart A. Kinner, Mohammad R. Hayatbakhsh, Abdullah Al Mamun, Jake M. Najman & Gail M. Williams. (2008) Pathways to ecstasy use in young adults: Anxiety, depression or behavioural deviance?. Drug and Alcohol Dependence 92:1-3, pages 108-115.
Crossref
Crossref
Olaf H. Drummer. 2008. Essentials of Autopsy Practice. Essentials of Autopsy Practice
1
21
.
Sergio Abanades, Magi Farré, Diego Barral, Marta Torrens, Neus Closas, Klaus Langohr, Antoni Pastor & Rafael de la Torre. (2007) Relative Abuse Liability of γ-Hydroxybutyric Acid, Flunitrazepam, and Ethanol in Club Drug Users. Journal of Clinical Psychopharmacology 27:6, pages 625-638.
Crossref
Crossref
Andrea L. Stone, Megan S. O’Brien, Alejandro De La Torre & James C. Anthony. (2007) Who is becoming hallucinogen dependent soon after hallucinogen use starts?. Drug and Alcohol Dependence 87:2-3, pages 153-163.
Crossref
Crossref
Arpana Agrawal, Michael T. Lynskey, Pamela A. F. Madden, Kathleen K. Bucholz & Andrew C. Heath. (2006) A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 102:1, pages 94-104.
Crossref
Crossref
Lawrence P Carter, Brian D Richards, Miriam Z Mintzer & Roland R Griffiths. (2006) Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB. Neuropsychopharmacology 31:11, pages 2537-2551.
Crossref
Crossref
E. Visser & S.A. Schug. (2006) The role of ketamine in pain management. Biomedicine & Pharmacotherapy 60:7, pages 341-348.
Crossref
Crossref
Emily E. Tanner-Smith. (2006) Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service. Drug and Alcohol Dependence 83:3, pages 247-254.
Crossref
Crossref
Silvia S. Martins, Guido Mazzotti & Howard D. Chilcoat. (2006) Recent-onset ecstasy use: Association with deviant behaviors and psychiatric comorbidity.. Experimental and Clinical Psychopharmacology 14:3, pages 275-286.
Crossref
Crossref
Cameron Duff. (2018) “Charging” and “Blowing Out”: Patterns and Cultures of GHB Use in Melbourne, Australia. Contemporary Drug Problems 32:4, pages 605-653.
Crossref
Crossref